Aug. 26, 2022

MRTX0902: A Brain-Penetrant SOS1:KRAS Protein-Protein Interaction Inhibitor

MRTX0902

oral brain-penetrant SOS1:KRASG12C PPI inhibitor efficacy in MIA PaCa-2 tumor mouse xenograft model from literature starting point and opt J. Med. Chem., July 14, 2022 Mirati Therapeutics, San Diego, CA

twitterlinkedinprintemail